<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00116441</url>
  </required_header>
  <id_info>
    <org_study_id>K-0007</org_study_id>
    <secondary_id>K-0007</secondary_id>
    <nct_id>NCT00116441</nct_id>
  </id_info>
  <brief_title>Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma</brief_title>
  <official_title>Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cell Genesys</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cell Genesys</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of vaccination with
      autologous myeloma cells and an allogeneic granulocyte-macrophage colony stimulating factor
      (GM-CSF) producing cell line.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2000</start_date>
  <completion_date>October 2004</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Multiple myeloma</measure>
  </primary_outcome>
  <enrollment>22</enrollment>
  <condition>Multiple Myeloma</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Therapeutic Cellular Vaccine, GM-CSF Producing</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  De novo multiple myeloma

          -  ECOG 0-2

          -  No serious co-morbid illnesses and adequate organ function

          -  &gt; 4 weeks from systemic steroids

        Exclusion Criteria:

          -  No existing secondary malignancies and no history of secondary malignancies in the
             past 5 years

          -  No active autoimmune disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2005</study_first_submitted>
  <study_first_submitted_qc>June 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2005</study_first_posted>
  <last_update_submitted>December 18, 2007</last_update_submitted>
  <last_update_submitted_qc>December 18, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2007</last_update_posted>
  <keyword>Multiple Myeloma</keyword>
  <keyword>Cancer</keyword>
  <keyword>PSCT</keyword>
  <keyword>Peripheral Stem Cell Transplant</keyword>
  <keyword>Chemotherapy</keyword>
  <keyword>GVAX</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

